Websites using cardiac event as a keyword

London Heart Centre was founded by a group of London cardiologists as a cardiac diagnostic centre providing range of services like ECG, Exercise test, Heart rate monitoring, 24 hour blood pressure monitoring, Cardiac event monitoring.

The AliveCor Mobile ECG and Heart Monitor for iPhone and Android. A single lead cardiac event recorder, originally developed by Alive Technologies in collaboration with US physician and entrepreneur Dr Albert. Now available in Australia.

Healthy Keralam.com is an malayalam health initiative started by Ethnic Health Court.

ECG interpretation & reporting services for 12 lead ECG, 24 hour tape and event recorder tests - 24/7/365 cardiac monitoring centre - UK nationwide

Sudden Cardiac Arrest (SCA) occurs when there is a problem with the heart’s electrical activity, resulting in the heart being unable to perform its vital job of pumping blood around the body. There is usually no warning that an arrest is about to happen and often no history of any heart trouble. The person will lose consciousness…

Singapore Emergency Ambulance Services provides a full range of medical services to meet your event needs from Emergency First Responder to a fleet of Emergency Ambulances supported by Medical Doctors, Registered Nurses, Physiotherapists and Paramedics.

First-Call Medical is a Nationwide Diagnostic Testing Facility specializing in the analysis of EKG from Holter, Cardiac Event and Pacemaker Monitors.

Techindia is Asia's largest cardiac rhythm, cardiac arrhythmia, cardiac event monitoring and remote patient monitoring company. We also focus on healthcare revenue cycle management services. Contact us today!

The Heart Rhythm Society will host the brightest minds in cardiac pacing and electrophysiology at the annual Scientific Sessions. This renowned, global event will provide the latest science, best practices, and forums for peer-to-peer discussions and debate.

Find information for healthcare professionals about Rituxan® (rituximab), the only FDA-approved treatment proven to induce remission in patients with GPA and MPA. INDICATION STATEMENT - Rituxan® (rituximab), in combination with glucocorticoids, is indicated for the treatment of adult patients with Granulomatosis with Polyangiitis (GPA) (Wegener’s Granulomatosis) and Microscopic Polyangiitis (MPA) - Limitations of Use: Rituxan is not recommended for use in patients with severe, active infections BOXED WARNINGS and Additional Important Safety Information BOXED WARNINGS Infusion Reactions: Rituxan administration can result in serious, including fatal, infusion reactions. Deaths within 24 hours of Rituxan infusion have occurred. Approximately 80% of fatal infusion reactions occurred in association with the first infusion. Monitor patients closely. Discontinue Rituxan infusion for severe reactions and provide medical treatment for Grade 3 or 4 infusion reactions. Severe Mucocutaneous Reactions: Severe, including fatal, mucocutaneous reactions can occur in patients receiving Rituxan. Hepatitis B Virus (HBV) Reactivation: HBV reactivation can occur in patients treated with Rituxan, in some cases resulting in fulminant hepatitis, hepatic failure, and death. Screen all patients for HBV infection before treatment initiation, and monitor patients during and after treatment with Rituxan. Discontinue Rituxan and concomitant medications in the event of HBV reactivation. Progressive Multifocal Leukoencephalopathy (PML): PML, including fatal PML, can occur in patients receiving Rituxan. Warnings and Precautions Rituxan administration can also result in additional serious, including fatal, adverse reactions including: - Tumor lysis syndrome (TLS): Administer aggressive intravenous hydration, anti‑hyperuricemic agents, monitor renal function - Infections: Withhold Rituxan and institute appropriate anti-infective therapy - Cardiac arrhythmias and angina: Discontinue infusions in case of serious or life-threatening events - Bowel obstruction and perforation: Consider and evaluate for abdominal pain, vomiting, or related symptoms - Live virus vaccines: Do not administer live virus vaccines prior to or during Rituxan - Cytopenias: Monitor blood counts at regular intervals Granulomatosis With Polyangiitis (GPA) (Wegener’s Granulomatosis) and Microscopic Polyangiitis (MPA) - Use of concomitant immunosuppressants other than corticosteroids has not been studied in GPA or MPA patients exhibiting peripheral B-cell depletion following treatment with Rituxan. Observe patients with GPA and MPA closely for signs of infection if immunosuppressants other than corticosteroids are used concomitantly - The safety and efficacy of retreatment with Rituxan have not been established in patients with GPA and MPA - Common adverse reactions (≥15%) in the clinical study were infections, nausea, diarrhea, headache, muscle spasms, anemia, and peripheral edema. Other important adverse reactions include infusion reactions You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555. For additional safety information, please see the Rituxan full prescribing information, including BOXED WARNINGS.

CardiacMonitoring.com reviews all companies & monitor technology for Holter monitoring, cardiac event monitoring & mobile cardiac telemetry (MCT).

Welcome on the Cardiostim 2016 website!

WELCOME TO EACTS Founded in 1986 we represent over 3,000 surgeons and our mission is to advance education in the field of cardiac, thoracic and vascular interventions and promote and disseminate research into cardiovascular and thoracic physiology, pathology and therapy.

Quantifying Vital Signals. Accurately. See how our innovative technology can assist with ECG noise filtering, heart rate measurement, arrhythmia detection, interval measurement, and cardiac safety screening.

Perth defibrillators - Portable defibrillators. The LIFEPAK CR Plus automated external defibrillator (AED) is easy and quick to use in the event of a cardiac emergency.

Providing accurate mobile cardiac telemetry leads to faster diagnosis for arrhythmia patients. Call 800-23-HEART for more information.